{"count": 2, "results": [{"_id": "18533158", "pmid": 18533158, "title": "The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.", "journal": "Atherosclerosis", "authors": ["Hajer GR", "Dallinga-Thie GM", "van Vark-van der Zee LC", "Visseren FL"], "date": "2009-01-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2008.04.035", "meta_date_publication": "2009 Jan", "meta_volume": "202", "meta_issue": "1", "meta_pages": "216-24", "score": 50079.42, "text_hl": "METHODS: Prospective, randomized, double blind, crossover trial. Male @<m>DISEASE_Obesity_Metabolically_Benign</m> @DISEASE_MESH:D000067329 @@@obese metabolic syndrome@@@ (ATPIII) @SPECIES_9606 @@@patients@@@ (n=19) were treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 80mg and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@/@CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10mg/10mg for 6 weeks. ", "citations": {"NLM": "Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Visseren FL. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients. Atherosclerosis. 2009 Jan;202(1):216-24. PMID: 18533158", "BibTeX": "@article{18533158, title={The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.}, author={Hajer GR and Dallinga-Thie GM and van Vark-van der Zee LC and Visseren FL}, journal={Atherosclerosis}, volume={202}, number={1}, pages={216-24}}"}}, {"_id": "18394022", "pmid": 18394022, "title": "Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.", "journal": "Clin Endocrinol (Oxf)", "authors": ["Hajer GR", "Dallinga-Thie GM", "van Vark-van der Zee LC", "Olijhoek JK", "Visseren FL"], "date": "2008-12-01T00:00:00Z", "doi": "10.1111/j.1365-2265.2008.03250.x", "meta_date_publication": "2008 Dec", "meta_volume": "69", "meta_issue": "6", "meta_pages": "870-7", "score": 50051.062, "text_hl": "METHODS: Prospective, randomized, double blind, crossover trial comparing @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 80 mg with @CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination @CHEMICAL_MESH:D000069499 @@@simvastatin/ezetimibe@@@ 10 mg/10 mg @DISEASE_Neoplasms_Second_Primary @DISEASE_MESH:D016609 @@@treatment@@@ for 6 weeks on postprandial HDL-c metabolism in 15, nonsmoking, male, @<m>DISEASE_Obesity_Metabolically_Benign</m> @DISEASE_MESH:D000067329 @@@obese metabolic syndrome@@@ @SPECIES_9606 @@@patients@@@ (Adult @DISEASE_Neoplasms_Second_Primary @DISEASE_MESH:D016609 @@@Treatment@@@ Panel @DISEASE_Rufous_oculocutaneous_albinism @DISEASE_MESH:C537189 @@@III@@@, ATPIII). ", "citations": {"NLM": "Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial. Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. PMID: 18394022", "BibTeX": "@article{18394022, title={Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.}, author={Hajer GR and Dallinga-Thie GM and van Vark-van der Zee LC and Olijhoek JK and Visseren FL}, journal={Clin Endocrinol (Oxf)}, volume={69}, number={6}, pages={870-7}}"}}]}